Eiko Lifesciences shines on getting nod to acquire 51% stake in SSM Formulations [Chemicals]
AI Summary1 min read
TL;DR
Eiko Lifesciences receives approval to acquire a 51% stake in SSM Formulations, boosting its investment portfolio in pharmaceutical and chemical sectors.
Tags
ChemicalsEiko LifesciencesSSM Formulationsacquisitioninvestmentchemicals
The company is carrying the business of an investment company and for that purpose to invest in, acquire, sell, transfer, subscribe for, hold and otherwise deal in and invest in any shares, bonds, stocks, obligations issued or guaranteed by any company constituted and carrying on business in India or elsewhere and debentures, debenture-stocks, bonds, obligations and securities issued or guaranteed by any Government, State, Sovereign, Commissioners Central or Provincial, public body or authority supreme, municipal, local or otherwise in India or elsewhere either out of its own funds or out of funds that it might borrow.